Mechanism of Action of Tofacitinib (Xeljanz)
Introduction Tofacitinib is an oral Janus kinase (JAK) inhibitor, primarily targeting JAK1 and JAK3. It blocks intracellular signaling … Read more
Mechanism of Action
Mechanism of Action of Liraglutide
Introduction Liraglutide is a long-acting GLP‑1 receptor agonist, injected once daily. It’s used for type 2 diabetes mellitus … Read more
Mechanism of Action of SGLT2Inhibitors
Introduction SGLT2 inhibitors, also known as “gliflozins,” are a class of oral antidiabetic agents primarily used to manage … Read more
Mechanism of Action of Semaglutide
Introduction Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA) used for type 2 diabetes mellitus (T2DM) management … Read more
Mechanism of Action of Tolvaptan
Introduction Tolvaptan is an oral vasopressin V₂ receptor antagonist, approved for treating hyponatremia due to SIADH, heart failure, … Read more
Mechanism of Action of Tocilizumab
Introduction Tocilizumab is a humanized monoclonal antibody targeting the interleukin-6 receptor (IL-6R). It is approved for rheumatoid arthritis … Read more
Mechanism of Action of Amantadine
Introduction Amantadine is an antiviral agent and antiparkinsonian medication. Initially used for influenza A, it also treats drug-induced … Read more
Mechanism of Action of Jardiance (Empagliflozin)
Introduction Jardiance (empagliflozin) is a sodium–glucose co-transporter 2 (SGLT2) inhibitor used for type 2 diabetes mellitus (T2DM), heart failure … Read more
Mechanism of Action of Apremilast (Otezla)
Introduction Apremilast (Otezla) is an oral phosphodiesterase-4 (PDE4) inhibitor approved for psoriasis, psoriatic arthritis, and Behçet’s disease‑associated oral … Read more
Mechanism of Action of Eculizumab (Soliris)
Introduction Eculizumab is a humanized monoclonal antibody that selectively binds to complement protein C5, inhibiting its cleavage and … Read more